Tags:Drug
A biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. (NASDAQ: NXTC)

Investors 3

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
09.05.2019Four biote...NextCure, based in Beltsville,...--medcitynew...
13.11.2018NextCure C...-Portfolio ...-sofinnova....
06.01.2016NextCure R...NextCure, Inc., a newly formed...USA-finsmes.co...